132487-14-0

Basic information

• Product Name: Aids002191
• Synonyms: 1,2-Cyclopropanedimethanol, 3-(6-amino-9H-purin-9-yl)-, (1.alpha.,2.alpha.,3.beta.)-;9-(2,3-Diohch2cypr)a;Aids002191;Aids-002191
• CAS NO: 132487-14-0
• Molecular Formula: C10H13N5O2
• Molecular Weight: 235.24252
• Mol File: 132487-14-0.mol

Chemical Properties

• Boiling Point: 564.9°Cat760mmHg
• Flash Point: 295.4°C
• Appearance: /
• Density: 1.89g/cm³
• Vapor Pressure: 1.35E-13mmHg at 25°C
• Refractive Index: 1.896
• CAS DataBase Reference: Aids002191(CAS DataBase Reference)
• NIST Chemistry Reference: Aids002191(132487-14-0)
• EPA Substance Registry System: Aids002191(132487-14-0)

Safety Data

• Hazardous Substances Data: 132487-14-0(Hazardous Substances Data)

Usage

InChI:InChI=1/C10H13N5O2/c11-9-7-10(13-3-12-9)15(4-14-7)8-5(1-16)6(8)2-17/h3-6,8,16-17H,1-2H2,(H2,11,12,13)/t5-,6+,8?

Upstream product

• 132398-79-9 9-((2R,3R)-2,3-Bis-benzyloxymethyl-cyclopropyl)-9H-purin-6-ylamine 
• 132398-76-6 (2S,3S)-2,3-Bis-benzyloxymethyl-cyclopropylamine 
• 87-42-3 6-chloropurine 
• 1538584-49-4 (E)-3-(6-methoxy-9H-purin-9-yl)prop-2-en-1-ol 
• 1538583-91-3 6-methoxy-9-(propa-1,2-dien-1-yl)-9H-purine 
• 1538584-05-2 (E)-3-(6-methoxy-9H-purin-9-yl)allyl acetate 
• 68972-96-3 (Z)-1,4-dibenzyloxy-2-butene 
• 132398-78-8 9-((2R,3R)-2,3-Bis-benzyloxymethyl-cyclopropyl)-6-chloro-9H-purine 
• 132398-77-7 N⁴-((2R,3R)-2,3-Bis-benzyloxymethyl-cyclopropyl)-6-chloro-pyrimidine-4,5-diamine 
• 132398-75-5 ((2R,3R)-2,3-Bis-benzyloxymethyl-cyclopropyl)-carbamic acid methyl ester 
• 132398-74-4 C₂₀H₂₁NO₃ 

Relevant articles and documents

Synthesis of Chiral Cyclopropyl Carbocyclic Purine Nucleosides via Asymmetric Intramolecular Cyclopropanations Catalyzed by a Chiral Ruthenium(II) Complex

The synthesis of chiral cyclopropyl carbocyclic purine nucleoside analogues via the highly enantioselective intramolecular cyclopropanation reactions has been reported. With a chiral ruthenium(II)-phenyloxazoline complex as the catalyst, cyclopropyl carbocyclic purine nucleoside analogues containing three contiguous stereocenters were obtained with up to 99% yield and 99% ee. Furthermore, a chiral cyclopropyl carbocyclic adenosine nucleoside having anti-BLV activity could be synthesized in a concise manner using this strategy. (Figure presented.).